External validation of the recurrent falls risk scale in community-dwelling stroke individuals.

OBJECTIVE: To externally validate the Recurrent Fall Risk Scale (ReFR) in community-dwelling stroke survivors. METHODS: Cohort of stroke survivors with independent gait ability recruited from a reference outpatient stroke clinic. Besides sociodemographic and clinical data, the following scales were used: Modified Barthel Index (mBI), ReFR scale and National Institutes of Health Stroke Scale (NIHSS). Participants were followed up for 12 months to record the incidence of falls. Accuracy of the ReFR scale was measured by the area under the ROC curve. RESULTS: One hundred and thirteen individuals were recruited between April 2016 and November 2016: mean age 54 years (± 14), 55% women, median time since the last stroke 24 months (range 12 -48 months), posterior vascular territory affected in 35% of the sample. Median NIHSS was 3 (range 1 to 6), median mBI 49 (range 46-50), median ReFR 3 (range 2 to 5). During the follow-up period, 32 (33%) subjects had at least one fall and 18 (19%) were recurrent fallers (two or more falls). The accuracy of ReFR scale was 0.67 (95% CI = 0.54-0.79), p = 0.026. CONCLUSION: This study externally validated the ReFR as a tool to predict recurrent falls in individuals after stroke.

Age- and gender-specific associations between insomnia and falls in Boston Puerto Rican adults.

PURPOSE: This study evaluated the age- and gender-specific associations between insomnia and falls in community-dwelling Puerto Rican adults, independently of multiple covariates. METHODS: Cross-sectional data were collected from 954 Puerto Ricans, aged 46-79 years, in Boston, Massachusetts. In-person interviews were conducted to collect information on sociodemographics and lifestyle, mental status, medication use, comorbidities, sleep duration, insomnia symptoms, and falls and fractures. Blood and urine samples, and bone density measures were collected to assess C-reactive protein, serum interleukin-6, urinary cortisol, and bone mineral density. RESULTS: Multivariate robust Poisson regressions suggested that adults with insomnia had a 32 % increased likelihood of having falls (PR 1.32, p < 0.05), after adjustment for multiple covariates. Age and gender modified the effect of insomnia on risk of falls. Insomnia was significantly associated with higher risk of falls in adults of 60 years or older (PR 1.49, p < 0.05) and in women (PR 1.36, p < 0.05), but not in adults younger than 60 years or in men. Insomnia was not associated with recurrent falls or fractures. CONCLUSIONS: Age and gender need to be taken into account when considering treatment of insomnia in preventing geriatric falls. Well-designed evidence-based interventions to treat insomnia and improve sleep quality may reduce the risk of falls in this population.

Non-tricyclic and Non-selective Serotonin Reuptake Inhibitor Antidepressants and Recurrent Falls in Frail Older Women.

OBJECTIVE: To determine the risk of recurrent falls associated with antidepressants other than tricyclics (TCAs) and selective serotonin reuptake inhibitors (SSRIs) among frail older women. METHODS: This is a secondary analysis of the Zoledronic acid in frail Elders to STrengthen bone, or ZEST, trial data treated as a longitudinal cohort in 181 frail, osteoporotic women aged ≥65 years in long-term care. The primary exposure was individual non-TCA/non-SSRI antidepressants (i.e., serotonin norepinephrine reuptake inhibitors, mirtazapine, trazodone, and bupropion) at baseline and 6 months. The main outcome was recurrent (at least two) falls within 6 months after antidepressant exposure. Adjusted odds ratios (AORs) and 95% confidence intervals (CIs) were derived using a generalized estimating equations model. RESULTS: At least 15% of women experienced recurrent falls between 0-6 and 6-12 months. At baseline and 6 months, 18.2% and 6.9% had a non-TCA/non-SSRI antidepressant, respectively. Adjusting for demographics, health status, and other drugs that increase risk of falls, non-TCA/non-SSRI antidepressant exposure significantly increased the risk of recurrent falls (AOR: 2.14; 95% CI: 1.01-4.54). Fall risk further increased after removing bupropion from the non-TCA/non-SSRI antidepressant group in sensitivity analyses (AOR: 2.73; 95% CI: 1.24-6.01). CONCLUSIONS: Other antidepressant classes may not be safer than TCAs/SSRIs with respect to recurrent falls in frail older women.

Caídas frecuentes y neuroimágenes en paciente con parálisis supranuclearprogresiva. Presentación de caso y revisión de la literatura / Frequent falls neuroimaging in a patient with progressive supranuclear palsy

Las caídas en los adultos mayores son comunes, peligrosas y frecuentemente incapacitantes. Con frecuenciason multifactoriales y requieren un amplio abordaje diagnóstico. Las demencias, la enfermedad de Parkinsonidiopática (EP), la enfermedad cerebrovascular y las neuropatías se encuentran entre las condiciones neurológicasque con mayor frecuencia se asocian a caídas. Sin embargo, cuando estas se presentan con recurrenciaen el contexto de un síndrome parkinsoniano, particularmente al inicio de la enfermedad, deben sugerir eldiagnóstico de una parálisis supranuclear progresiva (PSP). Esta entidad es de diagnóstico esencialmente clínico;sin embargo, dado su pronóstico sombrío, se realizan imágenes por resonancia magnética (IRM) de cerebro atodos los pacientes para excluir otros diagnósticos alternativos y buscar hallazgos característicos de PSP. Estosson, principalmente, atrofia del mesencéfalo, borramiento de la sustancia nigra, atrofia del putamen y atrofiacon aumento de la señal del globo pálido.Se presenta a continuación el caso de un paciente adulto mayor que presentaba demencia y parkinsonismorefractario a levodopa, con caídas frecuentes, en quien la realización de una resonancia magnética sirvió paraaclarar el diagnóstico al evidenciar los hallazgos típicos de PSP. Además, se hace una breve revisión de losprincipales hallazgos con imágenes, de demencias parkinsonianas, y la prevención de caídas en estos pacientes.

Falls in the elderly are common, dangerous and often disabling. They are often multifactorial and require extensive diagnostic approach. Dementia, Idiopathic Parkinson's Disease, cerebrovascular disease and neuropathies are among the most frequent neurological condictions associated with falls. However, if a patient has had early instability and recurrent falls associated with a Parkinsonian syndrome, particularly at the beginning of the disease, it should suggest the diagnosis of Progressive Supranuclear Palsy (PSP). PSP is essentially a clinical diagnosis, however, given the bleak prognosis, Magnetic Resonance Imaging (MRI) of the brain is performed in all patients to exclude alternative diagnoses and to look for supporting features of PSP. These include signal increase and atrophy of the midbrain, thinning or smudging of the substantia nigra, atrophy of the putamen, atrophy and signal increase of globus pallidus.We present the case of an adult patient who had dementia and parkinsonism refractory to levodopa with frequent falls in whom typical findings of PSP were documented in MRI. In addition, a brief review of the main findings in Parkinsonian Dementias images and fall prevention in these patients.